Dedicated advocate of evidence-based medicine that I am, I am sometimes labeled by those who do not understand skepticism as a “shill” for big pharma. Of course, such accusations are simply the logical fallacy known as poisoning the well, in which the credulous engage in preemptive ad hominem attacks designed to associate me with the […]
Category: Clinical trials
As I mentioned a few days ago, I was at the ASCO Meeting over the weekend, arriving home Tuesday evening. ASCO has to be, as far as I can tell, the largest cancer meeting in the world. How big? 30,000 or so attendees big. Hundreds of sessions and talks big. Filling most of McCormick Center […]
It’s day three of the ASCO Meeting here in Chicago. So far, I have to say, it’s been a bit underwhelming. Unlike some years past, there don’t appear to have been any real blockbuster results to report; rather, lots of incremental studies were presented. There’s really only one study presented that I might blog, mainly […]
I love it. You see I noticed an old “friend,” the Herbinator, making this comment about me regarding dichloroacetate: I was listening to CBC Radio – the Current, as is my want, and there was a show on about DCA, or Dichloroacetic acid. DCA is a molecule so simple and cheap to make that drug […]
It never seems to end, does it? I’m talking about the hype and questionable practices revolving around dichloroacetate (DCA), the small molecule chemotherapeutic agent that targets the Warburg effect, in essence normalizing the metabolism of tumor cells and thereby inhibiting their growth. (See here and here for more details.) A report by Evangelos Michelakis at […]